International journal of gynaecology and obstetrics : the official organ of the International Federation of Gynaecology and Obstetrics
-
Int J Gynaecol Obstet · Jun 2000
Comparative Study Clinical Trial Controlled Clinical TrialLow-molecular-weight heparin for thrombophilia in pregnant women.
Low-molecular-weight heparin (LMWH) is the anticoagulant of choice during pregnancy because it is associated with a low incidence of osteoporosis and thrombocytopenia. Antithrombotic therapy has recently been used to prevent pregnancy loss in high-risk patients with evidence of acquired or congenital thrombophilia. The aim of the present study was to gain further information on the teratogenic potential of LMWH in this patient group. ⋯ Despite the small size of the study groups, our results support the assumption that the use of LMWH is safe, at least as a teratogenic agent, in patients with thrombophilia throughout pregnancy.
-
Int J Gynaecol Obstet · May 2000
Editorial Biography Historical ArticleAnnouncing the winner of the IJGO prize paper award for 1999.
-
Int J Gynaecol Obstet · Apr 2000
Comparative StudyCharacteristics of pregnant vs. non-pregnant women physicians: findings from the women physicians' health study.
Many young physicians are women, and many are in their childbearing years. Knowing pregnant physicians' status is useful for epidemiological and workforce reasons, yet no studies have compared pregnant with same-age, non-pregnant physicians, an especially appropriate comparison group. ⋯ The prenatal period may be a time of especially healthy habits and considerable productivity for female physicians.